ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Gilead DRN

Gilead DRN (GILD34)

260.72
4.23
( 1.65% )
Updated: 15:16:31

Gilead DRN Financial Summary

The current GILD34 market cap is 324.87B. The company's latest EPS is USD 4.5464 and P/E is 19.75.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 6.6B7.05B7.11B6.69B6.95B
Operating Income 1.67B2.63B1.61B-4.32B2.64B
Net Income 1.05B2.18B1.43B-4.17B1.61B
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 22.45B24.69B27.31B27.28B27.12B
Operating Income 4.29B4.07B9.92B7.33B7.61B
Net Income 5.39B123M6.23B4.59B5.67B
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 62.34B62.37B62.13B56.29B53.58B
Total Liabilities 41.24B40.13B39.38B38.84B35.38B
Total Equity 21.09B22.24B22.75B17.46B18.2B
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 61.63B68.41B67.95B63.17B62.13B
Total Liabilities 38.98B50.19B46.89B41.96B39.38B
Total Equity 22.65B18.22B21.06B21.21B22.75B
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 4.08B5.84B8.01B2.22B3.54B
Investing -1.31B-1.54B-2.27B-2.21B-2.51B
Financing -2.51B-4.03B-5.13B-1.36B-4.31B
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 9.14B8.17B11.38B9.07B8.01B
Investing -7.82B-14.62B-3.13B-2.47B-2.27B
Financing -7.63B770M-8.88B-6.47B-5.13B
Market Cap 324.87B
Price to Earnings Ratio 19.75
Price to Sales Ratio 4.13
Price to Cash Ratio 18.39
Price to Book Ratio 4.92
Dividend Yield 2.32%

Share Statistics

Shares Outstanding 1.25B
Average Volume (1 week) 72
Average Volume (1 Month) 60
52 Week Change 41.24%
52 Week High 261.04
52 Week Low 163.57
Spread (Intraday) 0.97 (0.37%)

Company Info

Company Name Gilead DRN
Address 1209 orange street
wilmington, delaware 19801
Website https://www.gilead.com
Industry biological pds,ex diagnstics (2836)